Rubius Therapeutics' IPO

Rubius Therapeutics raised a round of funding on July 18, 2018. Investors include Public.

Rubius Therapeutics is developing Red-Cell Therapeutics (RCTs) as a new treatment modality to address a wide array of indications including cancer, autoimmune disease, rare disease and metabolic disea…

Articles about Rubius Therapeutics' IPO: